메뉴 건너뛰기
Antimicrobial Agents and Chemotherapy
Volumn 60, Issue 7, 2016, Pages 3921-3933
Colistin and polymyxin B dosage regimens against Acinetobacter baumannii: Differences in activity and the emergence of resistance
Author keywords

[No Author keywords available]
Indexed keywords

COLISTIN; POLYMYXIN B; ANTIINFECTIVE AGENT;
EID: 84976878624     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02927-15     Document Type: Article
Times cited : (68)
References (61)
  • 1
    • 47949089607 scopus 로고    scopus 로고
    • Acinetobacter baumannii: Emergence of a successful pathogen
    • Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538-582. http://dx.doi.org/10.1128/CMR.00058-07.
    • (2008) Clin Microbiol Rev , vol.21 , pp. 538-582
    • Peleg, A.Y.1    Seifert, H.2    Paterson, D.L.3
  • 5
    • 79959248672 scopus 로고    scopus 로고
    • Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients
    • Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, Silveira FP, Forrest A, Nation RL. 2011. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother 55:3284-3294. http://dx.doi.org/10.1128/AAC.01733-10.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 3284-3294
    • Garonzik, S.M.1    Li, J.2    Thamlikitkul, V.3    Paterson, D.L.4    Shoham, S.5    Jacob, J.6    Silveira, F.P.7    Forrest, A.8    Nation, R.L.9
  • 6
    • 36448983944 scopus 로고    scopus 로고
    • Polymyxin B for the treatment of multidrug-resistant pathogens: A critical review
    • Zavascki AP, Goldani LZ, Li J, Nation RL. 2007. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 60:1206-1215. http://dx.doi.org/10.1093/jac/dkm357.
    • (2007) J Antimicrob Chemother , vol.60 , pp. 1206-1215
    • Zavascki, A.P.1    Goldani, L.Z.2    Li, J.3    Nation, R.L.4
  • 7
    • 84903952314 scopus 로고    scopus 로고
    • Colistin and polymyxin B: Peas in a pod, or chalk and cheese?
    • Nation RL, Velkov T, Li J. 2014. Colistin and polymyxin B: peas in a pod, or chalk and cheese? Clin Infect Dis 59:88-94. http://dx.doi.org/10.1093/cid/ciu213.
    • (2014) Clin Infect Dis , vol.59 , pp. 88-94
    • Nation, R.L.1    Velkov, T.2    Li, J.3
  • 13
    • 33744454666 scopus 로고    scopus 로고
    • Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
    • Bergen PJ, Li J, Rayner CR, Nation RL. 2006. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 50:1953-1958. http://dx.doi.org/10.1128/AAC.00035-06.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 1953-1958
    • Bergen, P.J.1    Li, J.2    Rayner, C.R.3    Nation, R.L.4
  • 14
    • 2442644015 scopus 로고    scopus 로고
    • Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate
    • Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K. 2004. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. J Antimicrob Chemother 53:837-840. http://dx.doi.org/10.1093/jac/dkh167.
    • (2004) J Antimicrob Chemother , vol.53 , pp. 837-840
    • Li, J.1    Milne, R.W.2    Nation, R.L.3    Turnidge, J.D.4    Smeaton, T.C.5    Coulthard, K.6
  • 16
    • 70350580290 scopus 로고    scopus 로고
    • Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock
    • Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, Dodek P, Wood G, Kumar A, Simon D, Peters C, Ahsan M, Chateau D, Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. 2009. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136:1237-1248. http://dx.doi.org/10.1378/chest.09-0087.
    • (2009) Chest , vol.136 , pp. 1237-1248
    • Kumar, A.1    Ellis, P.2    Arabi, Y.3    Roberts, D.4    Light, B.5    Parrillo, J.E.6    Dodek, P.7    Wood, G.8    Kumar, A.9    Simon, D.10    Peters, C.11    Ahsan, M.12    Chateau, D.13
  • 17
    • 30744446028 scopus 로고    scopus 로고
    • Appropriateness and delay to initiate therapy in ventilator-associated pneumonia
    • Luna CM, Aruj P, Niederman MS, Garzon J, Violi D, Prignoni A, Rios F, Baquero S, Gando S, Grupo Argentino de Estudio de la Neumonia Asociada al Respirador. 2006. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 27:158-164. http://dx.doi.org/10.1183/09031936.06.00049105.
    • (2006) Eur Respir J , vol.27 , pp. 158-164
    • Luna, C.M.1    Aruj, P.2    Niederman, M.S.3    Garzon, J.4    Violi, D.5    Prignoni, A.6    Rios, F.7    Baquero, S.8    Gando, S.9
  • 20
    • 59949094467 scopus 로고    scopus 로고
    • Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme
    • Yau W, Owen RJ, Poudyal A, Bell JM, Turnidge JD, Yu HH, Nation RL, Li J. 2009. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. J Infect 58:138-144. http://dx.doi.org/10.1016/j.jinf.2008.11.002.
    • (2009) J Infect , vol.58 , pp. 138-144
    • Yau, W.1    Owen, R.J.2    Poudyal, A.3    Bell, J.M.4    Turnidge, J.D.5    Yu, H.H.6    Nation, R.L.7    Li, J.8
  • 21
    • 84920971179 scopus 로고    scopus 로고
    • Antimicrobial heteroresistance: An emerging field in need of clarity
    • El-Halfawy OM, Valvano MA. 2015. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev 28:191-207. http://dx.doi.org/10.1128/CMR.00058-14.
    • (2015) Clin Microbiol Rev , vol.28 , pp. 191-207
    • El-Halfawy, O.M.1    Valvano, M.A.2
  • 26
    • 84960138976 scopus 로고    scopus 로고
    • New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: Smaller response in lung infection
    • Cheah SE, Wang J, Nguyen VT, Turnidge JD, Li J, Nation RL. 2015. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection. J Antimicrob Chemother http://dx.doi.org/10.1093/jac/dkv267.
    • (2015) J Antimicrob Chemother
    • Cheah, S.E.1    Wang, J.2    Nguyen, V.T.3    Turnidge, J.D.4    Li, J.5    Nation, R.L.6
  • 28
    • 84921041295 scopus 로고    scopus 로고
    • Directorate for the Quality of Medicines and HealthCare of the Council of Europe. European Pharmacopoeia 8.0. Directorate for the Quality of Medicines and HealthCare of the Council of Europe, Strasbourg, France
    • Directorate for the Quality of Medicines and HealthCare of the Council of Europe. 2014. Monographs for colistimethate sodium and colistin sulfate, p 1960-1962. European Pharmacopoeia 8.0. Directorate for the Quality of Medicines and HealthCare of the Council of Europe, Strasbourg, France.
    • (2014) Monographs for Colistimethate Sodium and Colistin Sulfate , pp. 1960-1962
  • 29
    • 84894087843 scopus 로고    scopus 로고
    • Development and validation of a liquid chromatography-mass spectrometry assay for polymyxin B in bacterial growth media
    • Cheah SE, Bulitta JB, Li J, Nation RL. 2014. Development and validation of a liquid chromatography-mass spectrometry assay for polymyxin B in bacterial growth media. J Pharm Biomed Anal 92:177-182. http://dx.doi.org/10.1016/j.jpba.2014.01.015.
    • (2014) J Pharm Biomed Anal , vol.92 , pp. 177-182
    • Cheah, S.E.1    Bulitta, J.B.2    Li, J.3    Nation, R.L.4
  • 30
    • 77951247743 scopus 로고    scopus 로고
    • Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model
    • Bulitta JB, Yang JC, Yohonn L, Ly NS, Brown SV, D'Hondt RE, Jusko WJ, Forrest A, Tsuji BT. 2010. Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model. Antimicrob Agents Chemother 54:2051-2062. http://dx.doi.org/10.1128/AAC.00881-09.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 2051-2062
    • Bulitta, J.B.1    Yang, J.C.2    Yohonn, L.3    Ly, N.S.4    Brown, S.V.5    D'Hondt, R.E.6    Jusko, W.J.7    Forrest, A.8    Tsuji, B.T.9
  • 32
    • 0031714134 scopus 로고    scopus 로고
    • Application of logistic growth model to pharmacodynamic analysis of in vitro bactericidal kinetics
    • Yano Y, Oguma T, Nagata H, Sasaki S. 1998. Application of logistic growth model to pharmacodynamic analysis of in vitro bactericidal kinetics. J Pharm Sci 87:1177-1183. http://dx.doi.org/10.1021/js9801337.
    • (1998) J Pharm Sci , vol.87 , pp. 1177-1183
    • Yano, Y.1    Oguma, T.2    Nagata, H.3    Sasaki, S.4
  • 33
    • 15944387317 scopus 로고    scopus 로고
    • The viable but nonculturable state in bacteria
    • Oliver JD. 2005. The viable but nonculturable state in bacteria. J Microbiol 43:93-100.
    • (2005) J Microbiol , vol.43 , pp. 93-100
    • Oliver, J.D.1
  • 34
    • 77953206132 scopus 로고    scopus 로고
    • Recent findings on the viable but nonculturable state in pathogenic bacteria
    • Oliver JD. 2010. Recent findings on the viable but nonculturable state in pathogenic bacteria. FEMS Microbiol Rev 34:415-425. http://dx.doi.org/10.1111/j.1574-6976.2009.00200.x.
    • (2010) FEMS Microbiol Rev , vol.34 , pp. 415-425
    • Oliver, J.D.1
  • 35
    • 31444440959 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form
    • Schuck EL, Dalhoff A, Stass H, Derendorf H. 2005. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form. Infection 33(Suppl 2):S22-S28.
    • (2005) Infection , vol.33 , pp. S22-S28
    • Schuck, E.L.1    Dalhoff, A.2    Stass, H.3    Derendorf, H.4
  • 36
    • 33746919042 scopus 로고    scopus 로고
    • Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa
    • Tam VH, Kabbara S, Vo G, Schilling AN, Coyle EA. 2006. Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother 50:2626-2631. http://dx.doi.org/10.1128/AAC.01165-05.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 2626-2631
    • Tam, V.H.1    Kabbara, S.2    Vo, G.3    Schilling, A.N.4    Coyle, E.A.5
  • 37
    • 79960309927 scopus 로고    scopus 로고
    • The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A
    • Arroyo LA, Herrera CM, Fernandez L, Hankins JV, Trent MS, Hancock RE. 2011. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother 55:3743-3751. http://dx.doi.org/10.1128/AAC.00256-11.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 3743-3751
    • Arroyo, L.A.1    Herrera, C.M.2    Fernandez, L.3    Hankins, J.V.4    Trent, M.S.5    Hancock, R.E.6
  • 38
    • 84987804431 scopus 로고    scopus 로고
    • Mechanisms of polymyxin resistance: Acquired and intrinsic resistance in bacteria
    • Olaitan AO, Morand S, Rolain JM. 2014. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 5:643. http://dx.doi.org/10.3389/fmicb.2014.00643.
    • (2014) Front Microbiol , vol.5 , pp. 643
    • Olaitan, A.O.1    Morand, S.2    Rolain, J.M.3
  • 39
    • 34247887681 scopus 로고    scopus 로고
    • A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples
    • Bauer RJ, Guzy S, Ng C. 2007. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples. AAPS J 9:E60-E83. http://dx.doi.org/10.1208/aapsj0901007.
    • (2007) AAPS J , vol.9 , pp. E60-E83
    • Bauer, R.J.1    Guzy, S.2    Ng, C.3
  • 40
    • 79956327970 scopus 로고    scopus 로고
    • Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT
    • Bulitta JB, Bingolbali A, Shin BS, Landersdorfer CB. 2011. Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT. AAPS J 13:201-211. http://dx.doi.org/10.1208/s12248-011-9257-x.
    • (2011) AAPS J , vol.13 , pp. 201-211
    • Bulitta, J.B.1    Bingolbali, A.2    Shin, B.S.3    Landersdorfer, C.B.4
  • 41
    • 79957468849 scopus 로고    scopus 로고
    • Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models
    • Bulitta JB, Landersdorfer CB. 2011. Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models. AAPS J 13:212-226. http://dx.doi.org/10.1208/s12248-011-9258-9.
    • (2011) AAPS J , vol.13 , pp. 212-226
    • Bulitta, J.B.1    Landersdorfer, C.B.2
  • 42
    • 84855208923 scopus 로고    scopus 로고
    • Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patients
    • Bulitta JB, Landersdorfer CB, Forrest A, Brown SV, Neely MN, Tsuji BT, Louie A. 2011. Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patients. Curr Pharm Biotechnol 12:2044-2061. http://dx.doi.org/10.2174/138920111798808428.
    • (2011) Curr Pharm Biotechnol , vol.12 , pp. 2044-2061
    • Bulitta, J.B.1    Landersdorfer, C.B.2    Forrest, A.3    Brown, S.V.4    Neely, M.N.5    Tsuji, B.T.6    Louie, A.7
  • 43
    • 84881185263 scopus 로고    scopus 로고
    • Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs
    • Nielsen EI, Friberg LE. 2013. Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs. Pharmacol Rev 65:1053-1090. http://dx.doi.org/10.1124/pr.111.005769.
    • (2013) Pharmacol Rev , vol.65 , pp. 1053-1090
    • Nielsen, E.I.1    Friberg, L.E.2
  • 44
    • 84455173060 scopus 로고    scopus 로고
    • Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants
    • Mohamed AF, Nielsen EI, Cars O, Friberg LE. 2012. Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants. Antimicrob Agents Chemother 56:179-188. http://dx.doi.org/10.1128/AAC.00694-11.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 179-188
    • Mohamed, A.F.1    Nielsen, E.I.2    Cars, O.3    Friberg, L.E.4
  • 45
    • 35348938075 scopus 로고    scopus 로고
    • Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model
    • Tan CH, Li J, Nation RL. 2007. Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother 51:3413-3415. http://dx.doi.org/10.1128/AAC.01571-06.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 3413-3415
    • Tan, C.H.1    Li, J.2    Nation, R.L.3
  • 46
    • 84898606478 scopus 로고    scopus 로고
    • In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy
    • Phe K, Lee Y, McDaneld PM, Prasad N, Yin T, Figueroa DA, Musick WL, Cottreau JM, Hu M, Tam VH. 2014. In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy. Antimicrob Agents Chemother 58:2740-2746. http://dx.doi.org/10.1128/AAC.02476-13.
    • (2014) Antimicrob Agents Chemother , vol.58 , pp. 2740-2746
    • Phe, K.1    Lee, Y.2    McDaneld, P.M.3    Prasad, N.4    Yin, T.5    Figueroa, D.A.6    Musick, W.L.7    Cottreau, J.M.8    Hu, M.9    Tam, V.H.10
  • 48
    • 84886901842 scopus 로고    scopus 로고
    • Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center
    • Akajagbor DS, Wilson SL, Shere-Wolfe KD, Dakum P, Charurat ME, Gilliam BL. 2013. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center. Clin Infect Dis 57:1300-1303. http://dx.doi.org/10.1093/cid/cit453.
    • (2013) Clin Infect Dis , vol.57 , pp. 1300-1303
    • Akajagbor, D.S.1    Wilson, S.L.2    Shere-Wolfe, K.D.3    Dakum, P.4    Charurat, M.E.5    Gilliam, B.L.6
  • 49
    • 84865428411 scopus 로고    scopus 로고
    • Characterization of polymyxin B-induced nephrotoxicity: Implications for dosing regimen design
    • Abdelraouf K, Braggs KH, Yin T, Truong LD, Hu M, Tam VH. 2012. Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design. Antimicrob Agents Chemother 56:4625-4629. http://dx.doi.org/10.1128/AAC.00280-12.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 4625-4629
    • Abdelraouf, K.1    Braggs, K.H.2    Yin, T.3    Truong, L.D.4    Hu, M.5    Tam, V.H.6
  • 50
    • 84954544161 scopus 로고    scopus 로고
    • A PmrB-regulated deacetylase required for lipid A modification and polymyxin resistance in Acinetobacter baumannii
    • Chin CY, Gregg KA, Napier BA, Ernst RK, Weiss DS. 2015. A PmrB-regulated deacetylase required for lipid A modification and polymyxin resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 59:7911-7914. http://dx.doi.org/10.1128/AAC.00515-15.
    • (2015) Antimicrob Agents Chemother , vol.59 , pp. 7911-7914
    • Chin, C.Y.1    Gregg, K.A.2    Napier, B.A.3    Ernst, R.K.4    Weiss, D.S.5
  • 51
    • 84962082064 scopus 로고    scopus 로고
    • Distinguishing antimicrobial models with different resistance mechanisms via population pharmacodynamic modeling
    • Jacobs M, Gregoire N, Couet W, Bulitta JB. 2016. Distinguishing antimicrobial models with different resistance mechanisms via population pharmacodynamic modeling. PLoS Comput Biol 12:e1004782. http://dx.doi.org/10.1371/journal.pcbi.1004782.
    • (2016) PLoS Comput Biol , vol.12
    • Jacobs, M.1    Gregoire, N.2    Couet, W.3    Bulitta, J.B.4
  • 52
    • 77952597327 scopus 로고    scopus 로고
    • Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa
    • Gregoire N, Raherison S, Grignon C, Comets E, Marliat M, Ploy MC, Couet W. 2010. Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 54:2379-2384. http://dx.doi.org/10.1128/AAC.01478-08.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 2379-2384
    • Gregoire, N.1    Raherison, S.2    Grignon, C.3    Comets, E.4    Marliat, M.5    Ploy, M.C.6    Couet, W.7
  • 53
    • 84907879368 scopus 로고    scopus 로고
    • Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations
    • Fridman O, Goldberg A, Ronin I, Shoresh N, Balaban NQ. 2014. Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature 513:418-421. http://dx.doi.org/10.1038/nature13469.
    • (2014) Nature , vol.513 , pp. 418-421
    • Fridman, O.1    Goldberg, A.2    Ronin, I.3    Shoresh, N.4    Balaban, N.Q.5
  • 54
    • 84861503214 scopus 로고    scopus 로고
    • High-dose, extended-interval colistin administration in critically ill patients: Is this the right dosing strategy? A preliminary study
    • Dalfino L, Puntillo F, Mosca A, Monno R, Spada ML, Coppolecchia S, Miragliotta G, Bruno F, Brienza N. 2012. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study. Clin Infect Dis 54:1720-1726. http://dx.doi.org/10.1093/cid/cis286.
    • (2012) Clin Infect Dis , vol.54 , pp. 1720-1726
    • Dalfino, L.1    Puntillo, F.2    Mosca, A.3    Monno, R.4    Spada, M.L.5    Coppolecchia, S.6    Miragliotta, G.7    Bruno, F.8    Brienza, N.9
  • 57
    • 37849036253 scopus 로고    scopus 로고
    • Colistin heteroresistance in acinetobacter and its association with previous colistin therapy
    • Hawley JS, Murray CK, Jorgensen JH. 2008. Colistin heteroresistance in acinetobacter and its association with previous colistin therapy. Antimicrob Agents Chemother 52:351-352. http://dx.doi.org/10.1128/AAC.00766-07.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 351-352
    • Hawley, J.S.1    Murray, C.K.2    Jorgensen, J.H.3
  • 58
    • 77956119797 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model
    • Bergen PJ, Bulitta JB, Forrest A, Tsuji BT, Li J, Nation RL. 2010. Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model. Antimicrob Agents Chemother 54:3783-3789. http://dx.doi.org/10.1128/AAC.00903-09.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 3783-3789
    • Bergen, P.J.1    Bulitta, J.B.2    Forrest, A.3    Tsuji, B.T.4    Li, J.5    Nation, R.L.6
  • 59
    • 40049095690 scopus 로고    scopus 로고
    • Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: Studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
    • Bergen PJ, Li J, Nation RL, Turnidge JD, Coulthard K, Milne RW. 2008. Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. J Antimicrob Chemother 61:636-642. http://dx.doi.org/10.1093/jac/dkm511.
    • (2008) J Antimicrob Chemother , vol.61 , pp. 636-642
    • Bergen, P.J.1    Li, J.2    Nation, R.L.3    Turnidge, J.D.4    Coulthard, K.5    Milne, R.W.6
  • 61
    • 79956331997 scopus 로고    scopus 로고
    • Saturability of granulocyte kill of Pseudomonas aeruginosa in a murine model of pneumonia
    • Drusano GL, Vanscoy B, Liu W, Fikes S, Brown D, Louie A. 2011. Saturability of granulocyte kill of Pseudomonas aeruginosa in a murine model of pneumonia. Antimicrob Agents Chemother 55:2693-2695. http://dx.doi.org/10.1128/AAC.01687-10.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 2693-2695
    • Drusano, G.L.1    Vanscoy, B.2    Liu, W.3    Fikes, S.4    Brown, D.5    Louie, A.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.